Skip to main content

Table 2 Model outcomes in Australia 2010, compared against latest observed data

From: Expenditure and resource utilisation for cervical screening in Australia

 

Model predicted

Latest observed data†

Number of cytology performed

  

 20-69 years

2 million

2 million

 All ages

2.1 million

2.1 million

Number of low-grade cytology abnormalities detected in women 20–69 years

84,600

78,510††

Number of high-grade cytology abnormalities detected in women 20–69 years

27,700

28,491††

Number of women with abnormal cytology with a follow-up histological evaluation

33,200

38,859††

High-grade histology rate per 1,000 women screened

7.4

8.4

Age-standardised rate of cervical cancer incidence per 100,000 women‡

  

 20-69 years

8.9

9.3‡‡

 All ages

6.6

7‡‡

Age-standardised rate of cervical cancer incidence per 100,000 women‡

  

 20-69 years

2.1

1.9‡‡

 All ages

1.8

1.8‡‡

  1. † Data obtained from Cervical Screening in Australia 2009–2010 report [5].
  2. †† At the time of writing the latest available data was in 2009.
  3. ‡ Age-standardised to 2001 Australian population.
  4. ‡‡ At the time of writing the latest available data for cancer incidence was in 2008 and for cancer mortality was 2007.